BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Clarity commences theranostic prostate cancer trial

Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...

July 29, 2021 | News

VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant

New antiviral testing demonstrates SPL7013, the antiviral agent in VIRALEZE™ nasal spray, has potent virucidal activity against the globally signif...

July 28, 2021 | News

Collaborative Drug Discovery (CDD) Launches BioHarmony

Collaborative Drug Discovery, Inc. (CDD), provider of the web-based drug discovery informatics platform CDD Vault, announces the launch of a new data offer...

July 26, 2021 | News

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack

Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS&...

July 23, 2021 | News

Parkinson's Implements CDD Vault to Manage Its Drug Discovery Data

The Parkinson's Virtual Biotech, which launched in 2017, is a program that is plugging the funding gap in drug development to fast-track the projects with ...

July 19, 2021 | News

Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threaten...

July 13, 2021 | News

Biological E to purchase CpG 1018 adjuvant from Dynavax

DYNAVAX AND BIOLOGICAL E ANNOUNCE COMMERCIAL SUPPLY AGREEMENT OF DYNAVAX’S CpG 1018 ADJUVANT FOR BIOLOGICAL E’S COVID-19 VACCINE CANDIDATE Dyn...

July 06, 2021 | News

Roche to drive therapies to treat breast and lung cancer

According to Globocan, in 2020 the global burden of cancer increased to 19.3 million new cases and 10 million deaths[1]. Worldwide, the most common type of...

July 06, 2021 | News

SINOMED announces a clinical collaboration with the National University of Ireland Galway

The PIONEER IV trial is a prospective, random trial that will take place in 30 hospitals across Europe, enrolling 2,540 patients and involve patient...

July 05, 2021 | News

Arctic Vision to develop innovative therapies for pan-ocular diseases

Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today...

July 05, 2021 | News

10x Genomics to Leverage Robust Single-Cell Technologies for Drug Development

To Support Global BioPharma Companies Leveraging Robust Single-Cell Technologies for Accelerated and Improved Drug Development Genuity Science, a ge...

June 28, 2021 | News

SP launches SP Hull LyoStar(R) 4.0 to enhance speed to market in drug development

New advanced pilot-scale lyophilizer supports rapid and highly effective freezedry cycle development, optimization and process scale-up Based on a...

June 23, 2021 | News

Eurofins Discovery Expand their Antibody Discovery Platform

Eurofins Discovery's global clients will have access to ImmunoPrecise's end-to-end antibody discovery capabilities using wild type and best-in-class i...

June 23, 2021 | News

Australia's Viraleze™ is highly effective against Alpha, Beta and Gamma COVID variants

The results from the renowned Scripps Research Institute in the US confirm that SPL7013, the active ingredient in Viraleze™, is highly acti...

June 18, 2021 | News

Stay Connected